Posted by Defense World Staff on Feb 22nd, 2026
Barclays upgraded shares of Merck & Co., Inc. (NYSE:MRK – Free Report) to a strong-buy rating in a research note issued to investors on Thursday,Zacks.com reports.
A number of other equities analysts have also recently commented...
More of this article »